AI assistant
Sending…
Sarepta Therapeutics, Inc. — Director's Dealing 2011
Jan 10, 2011
31721_dirs_2011-01-10_5a97417a-8708-4b07-bf72-3a68a074135d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: AVI BIOPHARMA INC (AVII)
CIK: 0000873303
Period of Report: 2011-01-10
Reporting Person: Toshav Bracha Ephrat (Sr VP & General Counsel)
More from Sarepta Therapeutics, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4